Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -214

Accepted - Volume 3

Comment Record
Commentor Dr. Charles Holt, D.o. Date/Time 2002-11-08 18:23:37
Organization VA
Category Health Professional

Comments for FDA General
Questions
1. General Comments We must allow testing of all ages of patients--a bio-agent release as a WMD could be the end of modern history as we know it.




EC -214